The Anti-blue Ray Myopia Lenses Market Projected to Grow at a CAGR of 7.6% and Generate a Revenue of $5,361.10 million by 2030Download Sample Reports Overview
The global anti-blue ray myopia lenses market size is predicted to be valued at $5,361.10 million by 2030, surging from $2,280.80 million in 2021, at a noteworthy CAGR of 7.6%.
Impact Analysis of COVID-19 on the Anti-blue Ray Myopia Lenses Market
In the lockdown period during the COVID-19 outbreak, as individuals spent more time on smartphones, laptops, and digital screens, the COVID-19 impact on anti-blue ray myopia lenses market increased considerably. People were exposed to blue light for a longer period of time when using digital devices, which had an adverse effect on their eyes. As a result, the demand for anti-blue ray lenses increased. According to studies, the COVID-19 epidemic caused a rise in eye-related disorders as people were reluctant to go to the hospital for a routine checkup. Additionally, the percentage increased from 10% in 2019 to 50% in the last quarter of 2020, and the majority of those affected at the time had advanced cataracts. The market growth for anti-blue ray myopia lenses was favorably impacted by all of these factors during the COVID-19 pandemic.
However, several initiatives launched by the Essilor and Titan are helping society to recover from the pandemic. For instance, in August 2020, the launch of zero powered computer glasses was announced by Indian eyewear business Titan Eyeplus. These glasses, which come with anti-blue lenses, are available both online and offline. In light of the pandemic, all of these reasons are anticipated to have a beneficial effect on the market for anti-blue ray myopia lenses globally.
Global Anti-blue Ray Myopia Lenses Market Analysis
Myopia lenses that block blue rays are gaining popularity due to increasing lenses fashion trend and rising eye disease problems worldwide. According to analytical studies carried out by medical professionals, these glasses do aid to minimize eye strain and safeguard the eyes from harmful blue radiation. The use of anti-blue ray myopia lenses has several advantages, including a reduced risk of migraines and macular degeneration. Though a strong link between blue light and macular degeneration has not yet been conclusively proven, as per analysis that macular degeneration may be more likely if blue light is exposed frequently. As a result, many experts advise daily use of anti-blue ray myopia lenses to lower the likelihood of getting this condition. As a result, both the cause and the effect of migraines and headaches can be directly linked to eye strain. Thus, using these lenses can reduce the frequency and intensity of migraines.
However, anti-blue ray lenses are found to turn yellow over time due to various chemicals used in the lens production process, which is a growth-restricting problem for the sector. Such significant difficulties could have a detrimental effect on the market during the forecasted term.
The market for anti-blue ray myopia lenses is growing incredibly swiftly on a global scale as a result of people's rising desire to buy high-quality things for their eye protection. People all across the world demand designer and fashionable eyewear, according to current anti-blue ray myopia lenses market trends. Additionally, it is projected that growing trends in online virtual eyewear try-ons would hasten the market international expansion. Through the use of virtual try-ons, customers may select glasses from the comfort of their homes based on their preferences, wants, and likes. Due to the rising fashion awareness and living standards, the market for anti-blue ray myopia lenses is expanding favorably.
Global Anti-blue Ray Myopia Lenses Market Share, Segmentation
The global anti-blue ray myopia lenses market is segmented based on type, distribution channel, and region.
The type segment is further classified into single, bifocal, trifocal, and others. Among these, the single sub-segment is anticipated to have a dominant market share and surpass $2,666.50 million by 2030, with an increase from $1,072.90 million in 2021. The product's inexpensive cost and the fact that it is mostly for persons under 40 with nearsightedness (myopia) or other vision impairments can be credited for the market rise. A favorable impact on the segment might be seen throughout the projected period as a result of the increased number of vision-related abnormalities in younger children brought on by prolonged exposure to electronic devices. These defects will force kids to use anti-blue ray myopia lenses.
The distribution channel segment is further classified into retail stores, hospital & clinics, and e-commerce platforms. Among these, the retail stores sub-segment is anticipated to have a dominant market share and surpass $3,148.50 million by 2030, with an increase from $1,278.00 million in 2021. As branded and non-branded eyewear are more expensive, this expansion is predicted to enhance people's preferences for retail establishments. Additionally, a lot of optical shops provide certified optometrist exams for little to no cost or even free. As a result, customers choose to purchase eyeglasses from these retailers over other distribution channels. These elements can help the market generate a sizable amount of revenue over the course of the forecast period.
The anti-blue ray myopia lenses market share in the North America region is projected to show the fastest growth. This region’s market generated a revenue of $651.90 million in 2021 and is projected to reach up to $1,693.60 million by 2030. The anti-blue ray myopia lenses market outlook is increasing, particularly in the North American region, due to reasons such as the rising prevalence of eye-related diseases and increasing consumer spending on stylish eyeglasses and frames. Another important driver for the expansion of the anti-blue ray myopia lenses market growth in the region will be the significant presence of top anti-blue ray myopia lens suppliers and manufacturers.
Key Players in the Global Anti-blue Ray Myopia Lenses Market
Some of the leading anti-blue ray myopia lenses market players include
- HOYA Corporation
- RODENSTOCK GMBH
- Chemiglas Corp.
- Shamir Optical Industry Ltd
- Mingyue Glasses Co., Ltd.
- Shanghai Conant Optics Co., Ltd.
On November 10, 2020, – HOYA Surgical Optics, the worldwide leader in preloaded IOL delivery systems, obtained CE Mark for Qube pro powered by eyeflexa, a technology that can support both cataract and vitreoretinal surgery.